A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
Clinical trial NCT07265674 · RECRUITING
Trial details
- NCT number
- NCT07265674
- Sponsor
- J-Pharma Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-11
- Primary completion
- 2027-10-01
- Enrollment
- 480
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.